143 related articles for article (PubMed ID: 34909758)
41. Hyperinflammation and derangement of renin-angiotensin-aldosterone system in COVID-19: A novel hypothesis for clinically suspected hypercoagulopathy and microvascular immunothrombosis.
Henry BM; Vikse J; Benoit S; Favaloro EJ; Lippi G
Clin Chim Acta; 2020 Aug; 507():167-173. PubMed ID: 32348783
[TBL] [Abstract][Full Text] [Related]
42. Are Iranian Sulfur Mustard Gas-Exposed Survivors More Vulnerable to SARS-CoV-2? Some Similarity in Their Pathogenesis.
Farnoosh G; Ghanei M; Khorramdelazad H; Alishiri G; Jalali Farahani A; Shahriary A; Hosseini Zijoud SR
Disaster Med Public Health Prep; 2020 Dec; 14(6):826-832. PubMed ID: 32418550
[TBL] [Abstract][Full Text] [Related]
43. Pathogenesis-directed therapy of 2019 novel coronavirus disease.
Stratton CW; Tang YW; Lu H
J Med Virol; 2021 Mar; 93(3):1320-1342. PubMed ID: 33073355
[TBL] [Abstract][Full Text] [Related]
44. SARS-CoV-2 deregulates the vascular and immune functions of brain pericytes via Spike protein.
Khaddaj-Mallat R; Aldib N; Bernard M; Paquette AS; Ferreira A; Lecordier S; Saghatelyan A; Flamand L; ElAli A
Neurobiol Dis; 2021 Dec; 161():105561. PubMed ID: 34780863
[TBL] [Abstract][Full Text] [Related]
45. Pathomechanism and Management of Stroke in COVID-19: Review of Immunopathogenesis, Coagulopathy, Endothelial Dysfunction, and Downregulation of ACE2.
Rahmawati PL; Tini K; Susilawathi NM; Wijayanti IAS; Samatra DP
J Clin Neurol; 2021 Apr; 17(2):155-163. PubMed ID: 33835735
[TBL] [Abstract][Full Text] [Related]
46. Role of angiotensin-converting enzyme 2 (ACE2) in COVID-19.
Ni W; Yang X; Yang D; Bao J; Li R; Xiao Y; Hou C; Wang H; Liu J; Yang D; Xu Y; Cao Z; Gao Z
Crit Care; 2020 Jul; 24(1):422. PubMed ID: 32660650
[TBL] [Abstract][Full Text] [Related]
47. The Ineluctable Role of ACE-2 Receptors in SARS COV-2 Infection and Drug Repurposing as a Plausible SARS COV-2 Therapy: A Concise Treatise.
Joseph S; Nair B; Nath LR
Curr Mol Med; 2021; 21(10):888-913. PubMed ID: 33563197
[TBL] [Abstract][Full Text] [Related]
48. Vascular Endothelial Glycocalyx Damage in COVID-19.
Yamaoka-Tojo M
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33352699
[TBL] [Abstract][Full Text] [Related]
49. Understanding the Pathophysiology of COVID-19: Could the Contact System Be the Key?
Meini S; Zanichelli A; Sbrojavacca R; Iuri F; Roberts AT; Suffritti C; Tascini C
Front Immunol; 2020; 11():2014. PubMed ID: 32849666
[TBL] [Abstract][Full Text] [Related]
50. COVID-19 and dys-regulation of pulmonary endothelium: implications for vascular remodeling.
Jadaun PK; Chatterjee S
Cytokine Growth Factor Rev; 2022 Feb; 63():69-77. PubMed ID: 34728151
[TBL] [Abstract][Full Text] [Related]
51. Immune-Mediated Glycocalyx Remodeling in Hospitalized COVID-19 Patients.
Goonewardena SN; Grushko OG; Wells J; Herty L; Rosenson RS; Haus JM; Hummel SL
Cardiovasc Drugs Ther; 2023 Apr; 37(2):307-313. PubMed ID: 34792686
[TBL] [Abstract][Full Text] [Related]
52. Role of Endothelium in Cardiovascular Sequelae of Long COVID.
Santoro L; Zaccone V; Falsetti L; Ruggieri V; Danese M; Miro C; Di Giorgio A; Nesci A; D'Alessandro A; Moroncini G; Santoliquido A
Biomedicines; 2023 Aug; 11(8):. PubMed ID: 37626735
[TBL] [Abstract][Full Text] [Related]
53. Cardio-Oncology in the COVID Era (Co & Co): The Never Ending Story.
Bisceglia I; Canale ML; Gallucci G; Turazza FM; Lestuzzi C; Parrini I; Russo G; Maurea N; Quagliariello V; Oliva S; Di Fusco SA; Lucà F; Tarantini L; Trambaiolo P; Moreo A; Geraci G; Gabrielli D; Gulizia MM; Oliva F; Colivicchi F
Front Cardiovasc Med; 2022; 9():821193. PubMed ID: 35155636
[TBL] [Abstract][Full Text] [Related]
54. Pathophysiological Aspects of COVID-19-Associated Vasculopathic Diseases.
Greistorfer T; Jud P
Thromb Haemost; 2023 Oct; 123(10):931-944. PubMed ID: 37172941
[TBL] [Abstract][Full Text] [Related]
55. The misunderstood link between SARS-CoV-2 and angiogenesis. A narrative review.
Madureira G; Soares R
Pulmonology; 2023; 29(4):323-331. PubMed ID: 34593362
[TBL] [Abstract][Full Text] [Related]
56. COVID-19 and Pulmonary Angiogenesis: The Possible Role of Hypoxia and Hyperinflammation in the Overexpression of Proteins Involved in Alveolar Vascular Dysfunction.
Miggiolaro AFRS; da Silva FPG; Wiedmer DB; Godoy TM; Borges NH; Piper GW; Oricil AGG; Klein CK; Hlatchuk EC; Dagostini JCH; Collete M; Arantes MP; D'Amico RC; Dutra AA; de Azevedo MLV; de Noronha L
Viruses; 2023 Mar; 15(3):. PubMed ID: 36992415
[TBL] [Abstract][Full Text] [Related]
57. Cardiovascular signatures of COVID-19 predict mortality and identify barrier stabilizing therapies.
Gustafson D; Ngai M; Wu R; Hou H; Schoffel AC; Erice C; Mandla S; Billia F; Wilson MD; Radisic M; Fan E; Trahtemberg U; Baker A; McIntosh C; Fan CS; Dos Santos CC; Kain KC; Hanneman K; Thavendiranathan P; Fish JE; Howe KL
EBioMedicine; 2022 Apr; 78():103982. PubMed ID: 35405523
[TBL] [Abstract][Full Text] [Related]
58. SARS-CoV-2 Bound Human Serum Albumin and Systemic Septic Shock.
Johnson AS; Fatemi R; Winlow W
Front Cardiovasc Med; 2020; 7():153. PubMed ID: 33088822
[TBL] [Abstract][Full Text] [Related]
59. Can GPR4 Be a Potential Therapeutic Target for COVID-19?
Yang LV; Oppelt KA; Thomassen MJ; Marie MA; Nik Akhtar S; McCallen JD
Front Med (Lausanne); 2020; 7():626796. PubMed ID: 33553219
[TBL] [Abstract][Full Text] [Related]
60. SARS-CoV-2 and Endothelial Cells: Vascular Changes, Intussusceptive Microvascular Growth and Novel Therapeutic Windows.
Solimando AG; Marziliano D; Ribatti D
Biomedicines; 2022 Sep; 10(9):. PubMed ID: 36140343
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
